reference/32526456

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526456

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2749
issn	1945-7197 0021-972X
issueIdentifier	9
pageRange	2741-2749
publicationName	The Journal of clinical endocrinology and metabolism
startingPage	2741
bibliographicCitation	Brassard M, Neraud B, Trabado S, Salenave S, Brailly-Tabard S, Borget I, Baudin E, Leboulleux S, Chanson P, Schlumberger M, Young J. Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 2011 Sep;96(9):2741–9. doi: 10.1210/jc.2010-2771.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e39ee6de3feb5879e5f1a1d2f59644 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b038d8b6fb6102c56cc6b7a87d1e32f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc949ab5b48588273f30f6e253b3a2e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdff82be6712a6c5c75249afe8c9f8fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe1740e8fa8673f07733cef67e1ba5de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01254b0d79ced0da9b8baa2ab3d1def1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e74fa6d0629aa41a55b0d982a2e7247 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6295-6361 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe10e2ccfd4c46eddb9502fec4831368 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35355b9f6509c4d069c0c04050564fcc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6a8ff0f4ea19404bb7a896c5c5d8be6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd60b00fcc35970202f667e98ea24775
date	201109
identifier	https://pubmed.ncbi.nlm.nih.gov/21715537 https://doi.org/10.1210/jc.2010-2771
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4624 https://portal.issn.org/resource/ISSN/0021-972X https://portal.issn.org/resource/ISSN/1945-7197
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
discusses	http://id.nlm.nih.gov/mesh/M0003153 http://id.nlm.nih.gov/mesh/M0166929 http://id.nlm.nih.gov/mesh/M0260640 http://id.nlm.nih.gov/mesh/M0021196 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0022797 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0015931 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0185203 http://id.nlm.nih.gov/mesh/M0421253 http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004791Q000627 http://id.nlm.nih.gov/mesh/D013964Q000188 http://id.nlm.nih.gov/mesh/D000231Q000188 http://id.nlm.nih.gov/mesh/D018263Q000188 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D010880Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014807Q000097 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D040262Q000037 http://id.nlm.nih.gov/mesh/D051096Q000037 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D001786 http://id.nlm.nih.gov/mesh/D000231Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010281Q000097 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002118Q000097 http://id.nlm.nih.gov/mesh/D018592 http://id.nlm.nih.gov/mesh/D018263Q000097 http://id.nlm.nih.gov/mesh/D013739Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283711 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283710 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9419 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f02b83a26fc01f93e52937e4314d7c5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c5bd03db591d6af7691992d8435fa8e5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128344927 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 87.